Heparin versus bivalirudin for carotid artery stenting using proximal endovascular clamping for neuroprotection: Results from a prospective randomized study

Journal of Vascular Surgery

Volumn 52, Issue 6, 2010, Pages 1505-1510

  Stabile, Eugenio ^a   Sorropago, Giovanni ^a   Tesorio, Tullio ^a   Popusoi, Grigore ^a   Ambrosini, Vittorio ^a   Mottola, Maria Teresa ^a   Biamino, Giancarlo ^a   Rubino, Paolo ^a  

^a Clinica Montevergine   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; HIRULOG; TICLOPIDINE;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTERY CLAMP; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ENDOVASCULAR SURGERY; FEMALE; HEART INFARCTION; HEMIPARESIS; HUMAN; INTERNAL CAROTID ARTERY STENOSIS; INTRAOPERATIVE PERIOD; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROXIMAL ENDOVASCULAR CLAMPING; RANDOMIZED CONTROLLED TRIAL; STROKE; SURGICAL RISK; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; BALLOON OCCLUSION; BLOOD LOSS, SURGICAL; CAROTID ARTERY, INTERNAL; CAROTID STENOSIS; ENDOVASCULAR PROCEDURES; FEMALE; HEPARIN; HIRUDINS; HUMANS; MALE; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; STENTS; STROKE; THROMBOSIS; WHOLE BLOOD COAGULATION TIME;

EID: 78650202190     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.06.098     Document Type: Article

References (25)

1. J.S. Yadav, M.H. Wholey, R.E. Kuntz, P. Fayad, B.T. Katzen, G.J. Mishkel Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators Protected carotid-artery stenting versus endarterectomy in high-risk patients N Engl J Med 351 2004 1493 1501
2. E.R. Bates, J.D. Babb, D.E. Casey Jr, C.U. Cates, G.R. Duckwiler, and T.E. Feldman ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents J Am Coll Cardiol 49 2007 126 170
3. E. Young, T.J. Podor, T. Venner, and J. Hirsh Induction of acute phase reaction increases heparin-binding proteins in plasma Arterioscler Thromb Vasc Biol 17 1997 1568 1574
4. J. Hirsh, S.S. Anand, J.L. Halperin, and V. Fuster Guide to anticoagulant therapy: heparin A statement for health care professionals from the American Heart Association Circulation 103 2001 2994 3018
5. A.M. Lincoff, N.S. Kleiman, D.J. Kereiakes, F. Feit, J.A. Bittl, and J.D. Jackman Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial JAMA 292 2004 696 703
6. G.W. Stone, B.T. McLaurin, D.A. Cox, M.E. Bertrand, A.M. Lincoff, and J.W. Moses Bivaluridin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216
7. R.L. Bush, P.H. Lin, L. Mureebe, W. Zhou, E.K. Peden, and A.B. Lumsden Routine bivalirudin use in percutaneous carotid interventions J Endovasc Ther 12 2005 521 522
8. L.M. Schneider, S. Polena, G. Roubin, S. Iyer, J. Vitek, and G. Panagopoulos Carotid stenting and bivalirudin with and without vascular closure: 3-year analysis of procedural outcomes Catheter Cardiovasc Interv 75 2010 420 426
9. A. Kastrati, F.J. Neumann, J. Mehilli, R.A. Byrne, R. Iijima, and H.J. Bttner Bivalirudin versus unfractionated heparin during percutaneous coronary intervention N Engl J Med 359 2008 688 696
10. T.E. Warkentin, A. Greinacher, A. Koster, and A.M. Lincoff Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 133 2008 340S 380S
11. North American Symptomatic Carotid Endarterectomy Trial collaborators Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis N Engl J Med 325 1991 445 453
12. A. Halliday, A. Mansfield, J. Marro, C. Peto, R. Peto, and J. Potter Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomized controlled trial Lancet 363 2004 1491 1502
13. A. Cremonesi, C. Setacci, A. Bignamini, L. Bolognese, F. Briganti, and G. Di Sciascio Carotid artery stenting: first consensus document of the ICCS-SPREAD Joint Committee Stroke 37 2006 2400 2409
14. E. Stabile, G. Sorropago, T. Tesorio, L. Salemme, V. Ambrosini, and A. Cioppa Use of endovascular clamping as neuroprotection during carotid stenting in the presence of a critical ipsilateral stenosis of the external carotid artery EuroIntervention 3 2008 588 592
15. K.W. Diederich, D. Scheinert, A. Schmidt, S. Scheinert, B. Reimers, and H. Sievert First clinical experiences with an endovascular clamping system for neuroprotection during carotid stenting Eur J Vasc Endovasc Surg 28 2004 629 633
16. G. Coppi, R. Moratto, R. Silingardi, P. Rubino, G. Sarropago, and L. Salemme PRIAMUSproximal flow blockage cerebral protection during carotid stenting: results from a multicenter Italian registry J Cardiovasc Surg 46 2005 219 227 (Pubitemid 43932983)
17. B. Reimers, H. Sievert, G.C. Schuler, T. Tbler, K. Diederich, and A. Schmidt Proximal endovascular flow blockage for cerebral protection during carotid artery stenting: results from a prospective multicenter registry J Endovasc Ther 12 2005 156 165 (Pubitemid 40517048)
18. C.M. White Thrombin-directed inhibitors: pharmacology and clinical use Am Heart J 149 2005 S54 S60
19. H.B. Erdogan, D. Goksedef, V. Erentug, A. Polat, N. Bozbuga, and D. Mansuroglu In which patients should sheathless IABP be used? An analysis of vascular complications in 1211 cases J Card Surg 21 2006 342 346
20. A. Cremonesi, R. Manetti, F. Setacci, C. Setacci, and F. Castrista Protected carotid stenting clinical advantages and complications of embolic protection devices in 442 consecutive patients Stroke 34 2003 1936 1943
21. A.K. Rao, C. Pratt, A. Berke, A. Jaffe, I. Ockene, and T.L. Schreiber Thrombolysis In Myocardial Infarction (TIMI) trialPhase 1: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase J Am Coll Cardiol 11 1988 1 11
22. R.G. Newcombe, and D.G. Altman Proportions and their differences D.G. Altman, Statistics with confidenceconfidence intervals and statistical guidelines 2nd edition 2000 British Medical Journal London 45 56
23. Endovascular versus surgical treatment in patients with carotid stenosis in the CarotidVertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial Lancet 357 2001 1729 1737
24. J.L. Mas, G. Chatellier, B. Beyssen, A. Branchereau, T. Moulin, and J.P. Becquemin Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis N Engl J Med 355 2006 1660 1671
25. E. Stabile, L. Salemme, G. Sorropago, T. Tesorio, W. Nammas, and M. Miranda Proximal endovascular occlusion for carotid artery stenting: results from a prospective registry of 1,300 patients J Am Coll Cardiol 55 2010 1661 1667